0000899243-23-018603.txt : 20230830 0000899243-23-018603.hdr.sgml : 20230830 20230830172414 ACCESSION NUMBER: 0000899243-23-018603 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210427 FILED AS OF DATE: 20230830 DATE AS OF CHANGE: 20230830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nant Capital, LLC CENTRAL INDEX KEY: 0001675758 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37792 FILM NUMBER: 231226178 BUSINESS ADDRESS: BUSINESS PHONE: 310-836-6400 MAIL ADDRESS: STREET 1: 9922 JEFFERSON BOULEVARD CITY: CULVER CITY STATE: CA ZIP: 90232 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NantHealth, Inc. CENTRAL INDEX KEY: 0001566469 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 273019889 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3000 RDU CENTER DRIVE STREET 2: SUITE 200 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 8559496288 MAIL ADDRESS: STREET 1: 3000 RDU CENTER DRIVE STREET 2: SUITE 200 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: Nant Health, LLC DATE OF NAME CHANGE: 20130108 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2021-04-27 0 0001566469 NantHealth, Inc. NH 0001675758 Nant Capital, LLC 450 DULEY ROAD EL SEGUNDO CA 90245 0 0 1 0 4.50% Convertible Senior Notes due 2026 2026-04-27 Common Stock 16242206 D The Notes will be convertible at the option of the reporting persons at any time prior to the close of business on the business day immediately preceding the maturity date of the Notes. The Notes will be convertible into cash, shares of the issuer's common stock, or a combination thereof, at the issuer's election. The initial conversion rate of the 4.50% Convertible Senior Notes due 2026 (the "Notes") is 259.8753 shares of common stock per $1,000 principal amount of Notes (which is equivalent to an initial conversion price of approximately $3.85 per share), subject to adjustment pursuant to the terms of the Notes. The conversion rate and conversion price have not been adjusted to reflect the Reverse Split (as defined below). On December 15, 2022, the issuer effected a 1-for-15 reverse stock split (the "Reverse Stock Split") of its outstanding shares of common stock, par value $0.0001 per share ("Common Stock"). The numbers of shares reported on this Form 3 have not been adjusted to reflect the Reverse Split as it pertains to the number of shares of Common Stock that the reporting person beneficially owned as of the date that it became a reporting person. /s/ Charles Kenworthy, Manager, Nant Capital, LLC 2023-08-30